Navigation Links
MMV develops framework to assess risk of resistance for antimalarial compounds
Date:8/22/2012

Medicines for Malaria Venture has developed a framework to evaluate the risk of resistance for the antimalarial compounds in its portfolio. A paper based on this work: A framework for assessing the risk of resistance for antimalarials in development has been published in the Malaria Journal today.

Resistance defines the longevity of every anti-infective drug, so it is important when developing new medicines for malaria, to check how easily promising antimalarial compounds will select for resistance. Once this is known, it facilitates the prioritization of not only the most efficacious compounds but also the most robust ones.

"By profiling our portfolio as early as possible in terms of resistance liabilities, be they pre-existing or acquired, we are attempting to ensure that none of the compounds will fall to potential resistance," said Tim Wells, Chief Scientific Officer, MMV, and one of the authors of the paper. "This will also help us cost-effectively accelerate the drug development process, and be prepared in advance with a full resistance profile which is required by regulatory authorities before a new drug can be approved."

A cross-resistance test using a panel of multi-drug resistant strains of the parasite will check for pre-existing resistance liability. This will ensure that none of MMV's compounds are cross-resistant with other drugs, e.g., if a parasite is resistant to chloroquine, its resistance will also be profiled against MMV compounds.

The framework also includes selection experiments in the laboratory that measure how easy it is for the parasite to develop resistance, in other words, the likelihood of the occurrence of mutations that confer resistance. This is achieved by measuring the minimal inoculum for resistance (MIR) the minimum number of parasites from which a resistant one is likely to be selected by drug pressure. Although this is already being done, the framework offers a standard, systemat
'/>"/>

Contact: Jaya Banerji
banerjij@mmv.org
41-022-799-4071
Medicines for Malaria Venture
Source:Eurekalert

Page: 1 2

Related biology news :

1. US-Russian collaboration develops new method for sequencing dark matter of life from a single cell
2. University of Illinois professor develops tool that helps dietitians deliver info clients need and can understand
3. Pitt develops biodegradable artery graft to enhance bypass surgeries
4. MindSpec develops Autism Quiz app
5. Geneticist develops tool to identify genes important in disease, tailoring individual treatment
6. Pod corn develops leaves in the inflorescences
7. Genetic research develops tools for studying diseases, improving regenerative treatment
8. Diabetes Research Institute develops oxygen-generating biomaterial
9. Novo Nordisk and BGI establish global collaboration framework
10. Triage for plants: NYBG scientists develop and test rapid species conservation assessment technique
11. UCLA research makes possible rapid assessment of plant drought tolerance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/22/2014)... 21, 2014) -- There are all sorts of signaling ... spread their colorful tails; satin bowbirds build specialized stick ... shiny objects; and European bitterling males show off bright ... a unique method to communicate with others. , ... "Signaling can have profound fitness implications for individuals that ...
(Date:4/22/2014)... director of the University of Montana,s Wildlife Biology Program, co-wrote ... of the National Academy of Sciences on how streamwater ... ... the University of Washington, the Cary Institute of Ecosystem Studies, ... Research Station examined 664 water samples collected every 10 meters ...
(Date:4/22/2014)... Biotechnology scientists must be aware of the broad ... guidelines, according to a new paper from Rice University,s ... current issue of the journal Regenerative Medicine , ... Supreme Court ruling in the case Association for Molecular ... are unpatentable. The court case and rulings garnered discussion ...
Breaking Biology News(10 mins):Best practices in communication for the animal world 2Best practices in communication for the animal world 3New research focuses on streamwater chemistry, landscape variation 2New patenting guidelines are needed for biotechnology 2New patenting guidelines are needed for biotechnology 3
... common bean developed by Agricultural Research Service (ARS) and ... against the fungal disease common bean rust. ... Beltsville, Md., the new cultivars possess two or more ... the cultivars also harbor Ur-11, which is considered the ...
... PHOENIX, Ariz. June 3, 2010 A cancer ... Navajo people is helping bridge Western and Native American ... conference participants say more Navajos are learning about cancer, ... in cancer treatment and opening up to new therapies. ...
... The number of native fish and aquatic insects, especially those ... at low levels of development levels often considered protective ... U.S. Geological Survey. "When the area of driveways, parking ... a watershed area, many types of pollution sensitive aquatic insects ...
Cached Biology News:3rd annual Ft. Defiance Cancer Awareness Conference set for June 5 23rd annual Ft. Defiance Cancer Awareness Conference set for June 5 3Aquatic life declines at early stages of urban development 2
(Date:1/15/2014)... ON (PRWEB) January 15, 2014 AudioNotch ... experimental new therapy for the treatment of tinnitus. Patients ... tinnitus frequency, and over a period of weeks to months, ... Sound Therapy in two forms: Notched Music and Notched White ...
(Date:1/14/2014)... San Diego, CA (PRWEB) January 14, 2014 ... based on the products of cells grown under simulated ... an international license agreement with Suneva Medical, Inc. for ... media (CCM). , This agreement is an ...
(Date:1/14/2014)... Texas , Jan. 14, 2014 The ... and research medicinal plants and therapeutic derivatives thereof ... health professionals, and researchers about the challenges of ... http://photos.prnewswire.com/prnh/20100430/DC95601LOGO ) The Society ...
(Date:1/14/2014)...  RXi Pharmaceuticals Corporation (OTCQX: RXII), a biotechnology company ... addressing major unmet medical needs using RNA-targeted technologies, ... Allowance from the United States Patent and Trademark ... for the treatment of fibrosis. The patent covers ...
Breaking Biology Technology:Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 2World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 3World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 4World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 5World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 6World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 7World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 8RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 3
... flashPAGE Fractionator System , , ... The flashPAGE Fractionator System is the , fastest, easiest, and ... acids. Unlike traditional Polyacrylamide Gel Electrophoresis (PAGE), , which was ... Fractionator System is designed and optimized for the purification of RNA , ...
... The RiboPure-Blood Kit recovers , ... , ... expression profiles better than competing , technologies ... Extracting RNA from Blood , ...
... No longer must you endure the high cost , ... siRNA. The new Silencer siRNA Construction Kit , ... can expand , your capacity for large siRNA ... of the same gene can be screened for a fraction of the , ...
Cached Biology Technology:Ultra-Fast Purification of Small Nucleic Acids 2Ultra-Fast Purification of Small Nucleic Acids 3Ultra-Fast Purification of Small Nucleic Acids 4Ultra-Fast Purification of Small Nucleic Acids 5Total RNA from Whole Blood for Expression Profiling 2Total RNA from Whole Blood for Expression Profiling 3Total RNA from Whole Blood for Expression Profiling 4Total RNA from Whole Blood for Expression Profiling 5Test More siRNAs for Less 2Test More siRNAs for Less 3
... agitation and temperature control for microbiology and ... independently and is suitable for DASGIP bioreactors ... volume. Its temperature ranges from approximately 10 ... is equipped with an individual electrical heating ...
RORgamma (S-14)...
... the only microplate sealer with an integrated ... times with a variety of configurations and ... with integrated stacker and 240-plate storage capacity ... use in small workcells , Handles all ...
... LC Sciences provides a comprehensive service ... high density peptide microarrays synthesized on ... using recombinant proteins/antibodies or serum samples. ... your sequence designs, binding assays using ...
Biology Products: